Literature DB >> 11383859

The potential of intratumoural unsealed radioactive source therapy.

V R McCready, P Cornes.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11383859     DOI： 10.1007/s002590000380

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  6 in total

1.  Safety evaluation of 32P-chromic phosphate-poly L lactic acid particles interstitially implanted into livers of Beagle dogs.

Authors:  Lu Liu; Peilin Huang; Qi Nie; Benzhong Qi; Qinghua Wu; Hailin Gao; Zexuan Yang; Daming Chen
Journal:  Cancer Biother Radiopharm       Date:  2012-02-08       Impact factor: 3.099

2.  Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide.

Authors:  J Tyler French; Beth Goins; Marcela Saenz; Shihong Li; Xavier Garcia-Rojas; William T Phillips; Randal A Otto; Ande Bao
Journal:  J Vasc Interv Radiol       Date:  2010-05-15       Impact factor: 3.464

Review 3.  Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.

Authors:  Yu-Ping Xu; Min Yang
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

4.  Effective local control of prostate cancer by intratumoral injection of (166)Ho-chitosan complex (DW-166HC) in rats.

Authors:  Cheol Kwak; Sung Kyu Hong; Seung Kyoo Seong; Jei Man Ryu; Moon Soo Park; Sang Eun Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-31       Impact factor: 9.236

Review 5.  Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.

Authors:  Beth Goins; William T Phillips; Ande Bao
Journal:  Expert Opin Drug Deliv       Date:  2016-04-04       Impact factor: 6.648

Review 6.  Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

Authors:  William T Phillips; Ande Bao; Andrew J Brenner; Beth A Goins
Journal:  Adv Drug Deliv Rev       Date:  2014-07-09       Impact factor: 15.470
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.